We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warning Letter Roundup: Three Firms Slapped for Quality Issues
Warning Letter Roundup: Three Firms Slapped for Quality Issues
The FDA hit three overseas drugmakers for violations at their facilities that included testing deficiencies, a lack of cleaning validation and other slipups.